chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Paraesthesia, Peripheral swelling
Clinical narrative: Right arm was throbbing; whole right arm went numb; swollenness in her arm; tingling in her arm; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollenness in her arm), PARAESTHESIA (tingling in her arm), PAIN (Right arm was throbbing) and HYPOAESTHESIA (whole right arm went numb) in a 66-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 01L20A and 01LZ0A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 10-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollenness in her arm) and PARAESTHESIA (tingling in her arm). On 21-Feb-2021, the patient experienced HYPOAESTHESIA (whole right arm went numb). On 21-Feb-2021 at 6:30 PM, the patient experienced PAIN (Right arm was throbbing). The patient was treated with GABAPENTIN at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and Manual therapy (Therapeutic touch treatment) for Paraesthesia. On 28-Apr-2021, PAIN (Right arm was throbbing) and HYPOAESTHESIA (whole right arm went numb) had resolved. At the time of the report, PERIPHERAL SWELLING (swollenness in her arm) and PARAESTHESIA (tingling in her arm) outcome was unknown.            Treatment included Heating Pad.  No concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not Applicable   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow up received on 4-May-2021, reporter details, medical history, vaccination details(anatomical location), events and treatment details were added
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Feb-2021 and was forwarded to Moderna on 18-Feb-2021.    This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (Diarrhea) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included Colonoscopy (Normal) in 2019.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 17-FEB-2021 the patient experienced Inflammatory bowel condition   Most recent FOLLOW-UP information incorporated above includes: On 17-Feb-2021: No specific follow-up information recorded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Pain, Pyrexia, Vaccination site pain
Clinical narrative: feel blah; achy; 103 F fever; injection arm pain; injection arm lymph nodes swollen like a baseball; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel blah), PAIN (achy), PYREXIA (103 F fever), VACCINATION SITE PAIN (injection arm pain) and VACCINATION SITE SWELLING (injection arm lymph nodes swollen like a baseball) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (feel blah), PAIN (achy), PYREXIA (103 F fever), VACCINATION SITE PAIN (injection arm pain), VACCINATION SITE SWELLING (injection arm lymph nodes swollen like a baseball) and HEADACHE (headache). The patient was treated with IBUPROFEN at a dose of 800,400  milligram. At the time of the report, MALAISE (feel blah), PAIN (achy), PYREXIA (103 F fever), VACCINATION SITE PAIN (injection arm pain), VACCINATION SITE SWELLING (injection arm lymph nodes swollen like a baseball) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: feel blah; achy; 103 F fever; injection arm pain; injection arm lymph nodes swollen like a baseball; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel blah), PAIN (achy), PYREXIA (103 F fever), VACCINATION SITE PAIN (injection arm pain) and VACCINATION SITE SWELLING (injection arm lymph nodes swollen like a baseball) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (feel blah), PAIN (achy), PYREXIA (103 F fever), VACCINATION SITE PAIN (injection arm pain), VACCINATION SITE SWELLING (injection arm lymph nodes swollen like a baseball) and HEADACHE (headache). The patient was treated with IBUPROFEN at a dose of 800,400  milligram. At the time of the report, MALAISE (feel blah), PAIN (achy), PYREXIA (103 F fever), VACCINATION SITE PAIN (injection arm pain), VACCINATION SITE SWELLING (injection arm lymph nodes swollen like a baseball) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia
Clinical narrative: unable to stand; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (unable to stand) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. COMD19 and 012A21A) for COVID-19 vaccination.     The patient's past medical history included Myasthenia gravis. Concurrent medical conditions included Hypertension and Food allergy (Allergic to iodine). Concomitant products included METOPROLOL and LISINOPRIL for Hypertension, PYRIDOSTIGMINE BROMIDE (MESTINON) and PREDNISONE for Myasthenia gravis, AMLODIPINE, VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) and LORAZEPAM for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced DYSSTASIA (unable to stand). On 12-Feb-2021, DYSSTASIA (unable to stand) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant follow up received 20JUL 2021and concomitant medication were updated, patient demographics and medical history updated.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Migraine, Myalgia, Vomiting
Clinical narrative: very fatigued today; mild headache that progressed to a migraine; mild headache that progressed to a migraine; fatigue, muscle aches, and vomiting.; fatigue, muscle aches, and vomiting.; fatigue, muscle aches, and vomiting.; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (mild headache that progressed to a migraine), FATIGUE (fatigue, muscle aches, and vomiting.), MYALGIA (fatigue, muscle aches, and vomiting.), VOMITING (fatigue, muscle aches, and vomiting.) and FATIGUE (very fatigued today) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced HEADACHE (mild headache that progressed to a migraine), FATIGUE (fatigue, muscle aches, and vomiting.), MYALGIA (fatigue, muscle aches, and vomiting.), VOMITING (fatigue, muscle aches, and vomiting.) and MIGRAINE (mild headache that progressed to a migraine). On 02-Mar-2021, the patient experienced FATIGUE (very fatigued today). At the time of the report, HEADACHE (mild headache that progressed to a migraine), FATIGUE (fatigue, muscle aches, and vomiting.), MYALGIA (fatigue, muscle aches, and vomiting.) and VOMITING (fatigue, muscle aches, and vomiting.) was resolving, FATIGUE (very fatigued today) outcome was unknown and MIGRAINE (mild headache that progressed to a migraine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain in extremity
Clinical narrative: sore arm; arm hard to hold up; A spontaneous report was received from a consumer concerning a 67-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, arm hard to hold up.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) sore arm, arm hard to hold up.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), sore arm, arm hard to hold up was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Elevated heart bit 137bpm; oxygen level went down (90%); Typical pain arm (L injection); Body ache; Extreme fatigue; Joint pain; Fever (101°F is significant for her, because she typically has 96-97°F); Chills; Headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of TACHYCARDIA (Elevated heart bit 137bpm), OXYGEN SATURATION DECREASED (oxygen level went down (90%)), VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache) and FATIGUE (Extreme fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MONTELUKAST SODIUM (SINGULAIR), THIAMPHENICOL (IGRALIN) and ETHAMBUTOL DIHYDROCHLORIDE (ATB) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache), FATIGUE (Extreme fatigue), ARTHRALGIA (Joint pain), PYREXIA (Fever (101°F is significant for her, because she typically has 96-97°F)), CHILLS (Chills) and HEADACHE (Headache). On 28-Feb-2021, the patient experienced TACHYCARDIA (Elevated heart bit 137bpm) and OXYGEN SATURATION DECREASED (oxygen level went down (90%)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Elevated heart bit 137bpm), OXYGEN SATURATION DECREASED (oxygen level went down (90%)), VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache), FATIGUE (Extreme fatigue), ARTHRALGIA (Joint pain), PYREXIA (Fever (101°F is significant for her, because she typically has 96-97°F)), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 101 f (High) High. On 28-Feb-2021, Heart rate: 137 bpm (High) High. On 28-Feb-2021, Oxygen saturation: 90 % (Low) Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications included admix, sibotal 40 mg, immune deficiency medications (H2 and H2 peptide).
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Myalgia, Oxygen saturation, Oxygen saturation decreased, Pyrexia
Clinical narrative: Elevated heart bit 137bpm; oxygen level went down (90%); Typical pain arm (L injection); Body ache; Extreme fatigue; Joint pain; Fever (101°F is significant for her, because she typically has 96-97°F); Chills; Headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of TACHYCARDIA (Elevated heart bit 137bpm), OXYGEN SATURATION DECREASED (oxygen level went down (90%)), VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache) and FATIGUE (Extreme fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MONTELUKAST SODIUM (SINGULAIR), THIAMPHENICOL (IGRALIN) and ETHAMBUTOL DIHYDROCHLORIDE (ATB) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache), FATIGUE (Extreme fatigue), ARTHRALGIA (Joint pain), PYREXIA (Fever (101°F is significant for her, because she typically has 96-97°F)), CHILLS (Chills) and HEADACHE (Headache). On 28-Feb-2021, the patient experienced TACHYCARDIA (Elevated heart bit 137bpm) and OXYGEN SATURATION DECREASED (oxygen level went down (90%)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Elevated heart bit 137bpm), OXYGEN SATURATION DECREASED (oxygen level went down (90%)), VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache), FATIGUE (Extreme fatigue), ARTHRALGIA (Joint pain), PYREXIA (Fever (101°F is significant for her, because she typically has 96-97°F)), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 101 f (High) High. On 28-Feb-2021, Heart rate: 137 bpm (High) High. On 28-Feb-2021, Oxygen saturation: 90 % (Low) Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications included admix, sibotal 40 mg, immune deficiency medications (H2 and H2 peptide).
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Vaccination site pain
Clinical narrative: Elevated heart bit 137bpm; oxygen level went down (90%); Typical pain arm (L injection); Body ache; Extreme fatigue; Joint pain; Fever (101°F is significant for her, because she typically has 96-97°F); Chills; Headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of TACHYCARDIA (Elevated heart bit 137bpm), OXYGEN SATURATION DECREASED (oxygen level went down (90%)), VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache) and FATIGUE (Extreme fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MONTELUKAST SODIUM (SINGULAIR), THIAMPHENICOL (IGRALIN) and ETHAMBUTOL DIHYDROCHLORIDE (ATB) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache), FATIGUE (Extreme fatigue), ARTHRALGIA (Joint pain), PYREXIA (Fever (101°F is significant for her, because she typically has 96-97°F)), CHILLS (Chills) and HEADACHE (Headache). On 28-Feb-2021, the patient experienced TACHYCARDIA (Elevated heart bit 137bpm) and OXYGEN SATURATION DECREASED (oxygen level went down (90%)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Elevated heart bit 137bpm), OXYGEN SATURATION DECREASED (oxygen level went down (90%)), VACCINATION SITE PAIN (Typical pain arm (L injection)), MYALGIA (Body ache), FATIGUE (Extreme fatigue), ARTHRALGIA (Joint pain), PYREXIA (Fever (101°F is significant for her, because she typically has 96-97°F)), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 101 f (High) High. On 28-Feb-2021, Heart rate: 137 bpm (High) High. On 28-Feb-2021, Oxygen saturation: 90 % (Low) Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications included admix, sibotal 40 mg, immune deficiency medications (H2 and H2 peptide).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash, Vaccination site rash
Clinical narrative: rash on her back; rash on lesft side of injection arm; rash on her breast; shingles; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on her back), VACCINATION SITE RASH (rash on lesft side of injection arm), RASH (rash on her breast) and HERPES ZOSTER (shingles) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (Controlled high blood pressure). Concomitant products included TAMOXIFEN for Breast cancer, LOSARTAN POTASSIUM (COZAAR) for Hypertension.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced RASH (rash on her back), VACCINATION SITE RASH (rash on lesft side of injection arm), RASH (rash on her breast) and HERPES ZOSTER (shingles). On 10-Mar-2021, HERPES ZOSTER (shingles) had resolved. At the time of the report, RASH (rash on her back), VACCINATION SITE RASH (rash on lesft side of injection arm) and RASH (rash on her breast) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: Date of Birth of patient, first and second dose details, events after second dose were added On 29-Apr-2021: Patient's details such as height, weight, race and ethnicity, medical history, concomitant medications, outcome of event (shingles) changed
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Arm warm; Arm swollen; Could not sleep on arm; arm  really tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm warm), VACCINATION SITE SWELLING (Arm swollen), PAIN IN EXTREMITY (Could not sleep on arm) and VACCINATION SITE PAIN (arm  really tender) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Cholesterol. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Arm warm), VACCINATION SITE SWELLING (Arm swollen), PAIN IN EXTREMITY (Could not sleep on arm) and VACCINATION SITE PAIN (arm  really tender). At the time of the report, VACCINATION SITE WARMTH (Arm warm), VACCINATION SITE SWELLING (Arm swollen), PAIN IN EXTREMITY (Could not sleep on arm) and VACCINATION SITE PAIN (arm  really tender) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications included beta blockers and cholesterol medications. Treatment information was not reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Fatigue, Myalgia
Clinical narrative: diarrhea; Lost of appetite; extreme tired; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DECREASED APPETITE (Lost of appetite), FATIGUE (extreme tired) and MYALGIA (muscle aches) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced FATIGUE (extreme tired) and MYALGIA (muscle aches). On 09-Feb-2021, the patient experienced DIARRHOEA (diarrhea) and DECREASED APPETITE (Lost of appetite). On 09-Feb-2021, FATIGUE (extreme tired) and MYALGIA (muscle aches) had resolved. On 10-Feb-2021, DIARRHOEA (diarrhea) and DECREASED APPETITE (Lost of appetite) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Nausea, Pain
Clinical narrative: Brain Fog; Arm very sore; Chills at night time; Fatigue; nausea; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body Aches), FEELING ABNORMAL (Brain Fog), VACCINATION SITE PAIN (Arm very sore), CHILLS (Chills at night time) and FATIGUE (Fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arthritis. Concomitant products included FISH OIL and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Body Aches), VACCINATION SITE PAIN (Arm very sore), CHILLS (Chills at night time), FATIGUE (Fatigue) and NAUSEA (nausea). On 26-Feb-2021, the patient experienced FEELING ABNORMAL (Brain Fog). At the time of the report, PAIN (Body Aches), FEELING ABNORMAL (Brain Fog), VACCINATION SITE PAIN (Arm very sore), CHILLS (Chills at night time), FATIGUE (Fatigue) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Brain Fog; Arm very sore; Chills at night time; Fatigue; nausea; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body Aches), FEELING ABNORMAL (Brain Fog), VACCINATION SITE PAIN (Arm very sore), CHILLS (Chills at night time) and FATIGUE (Fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arthritis. Concomitant products included FISH OIL and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Body Aches), VACCINATION SITE PAIN (Arm very sore), CHILLS (Chills at night time), FATIGUE (Fatigue) and NAUSEA (nausea). On 26-Feb-2021, the patient experienced FEELING ABNORMAL (Brain Fog). At the time of the report, PAIN (Body Aches), FEELING ABNORMAL (Brain Fog), VACCINATION SITE PAIN (Arm very sore), CHILLS (Chills at night time), FATIGUE (Fatigue) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment provided.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore in arm; sore in thigh; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore in arm) and MYALGIA (sore in thigh) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore in arm) and MYALGIA (sore in thigh). At the time of the report, MYALGIA (sore in arm) and MYALGIA (sore in thigh) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Unable to capture reporter's contact details for further followup.   Reporter did not allow further contact
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Hyperhidrosis
Clinical narrative: chills; fatigue; headache; diarrhea; couldn't get out of bed for two days; lots of sweating; knot at injection site; body aching; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PAIN (body aching), LETHARGY (couldn't get out of bed for two days), HYPERHIDROSIS (lots of sweating) and INJECTION SITE NODULE (knot at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (body aching), INJECTION SITE NODULE (knot at injection site) and INJECTION SITE PAIN (pain at injection site). On an unknown date, the patient experienced DIARRHOEA (diarrhea), LETHARGY (couldn't get out of bed for two days), HYPERHIDROSIS (lots of sweating), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), PAIN (body aching), LETHARGY (couldn't get out of bed for two days), HYPERHIDROSIS (lots of sweating), INJECTION SITE NODULE (knot at injection site), HEADACHE (headache), INJECTION SITE PAIN (pain at injection site), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no relevant concomitant medications was reported. No treatment information was provided   Reporter did not allow further contact
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule, Injection site pain, Lethargy, Pain
Clinical narrative: chills; fatigue; headache; diarrhea; couldn't get out of bed for two days; lots of sweating; knot at injection site; body aching; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PAIN (body aching), LETHARGY (couldn't get out of bed for two days), HYPERHIDROSIS (lots of sweating) and INJECTION SITE NODULE (knot at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (body aching), INJECTION SITE NODULE (knot at injection site) and INJECTION SITE PAIN (pain at injection site). On an unknown date, the patient experienced DIARRHOEA (diarrhea), LETHARGY (couldn't get out of bed for two days), HYPERHIDROSIS (lots of sweating), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), PAIN (body aching), LETHARGY (couldn't get out of bed for two days), HYPERHIDROSIS (lots of sweating), INJECTION SITE NODULE (knot at injection site), HEADACHE (headache), INJECTION SITE PAIN (pain at injection site), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no relevant concomitant medications was reported. No treatment information was provided   Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain
Clinical narrative: Having aches; Slight diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Having aches) and DIARRHOEA (Slight diarrhea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) UNK dosage form. On an unknown date, the patient experienced PAIN (Having aches) and DIARRHOEA (Slight diarrhea). At the time of the report, PAIN (Having aches) and DIARRHOEA (Slight diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no relevant concomitant medications was reported. No treatment information was provided
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Oral pain, Rash
Clinical narrative: muscle pain, burning sensation and falling off, terrible pain in his muscles; joint pain; soreness in his mouth, burning inside his mouth; Rash; This spontaneous case was reported by a consumer and describes the occurrence of ORAL PAIN (soreness in his mouth, burning inside his mouth), RASH (Rash), ARTHRALGIA (joint pain) and MYALGIA (muscle pain, burning sensation and falling off, terrible pain in his muscles) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced RASH (Rash). On 13-Feb-2021, the patient experienced ORAL PAIN (soreness in his mouth, burning inside his mouth). On 22-Feb-2021, the patient experienced ARTHRALGIA (joint pain). On 26-Feb-2021, the patient experienced MYALGIA (muscle pain, burning sensation and falling off, terrible pain in his muscles). On 11-Feb-2021, RASH (Rash) had resolved. At the time of the report, ORAL PAIN (soreness in his mouth, burning inside his mouth), ARTHRALGIA (joint pain) and MYALGIA (muscle pain, burning sensation and falling off, terrible pain in his muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medicines were not included  Action taken with mRNA-1273 in response to the event was unknown
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysphonia, Myalgia, Vaccination site pain
Clinical narrative: injection arm extremely sore; Body Aches; chills; Voice became scratchy/Voice hoarseness progressing from littele to very hoarsing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (Voice became scratchy/Voice hoarseness progressing from littele to very hoarsing), VACCINATION SITE PAIN (injection arm extremely sore), MYALGIA (Body Aches) and CHILLS (chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced DYSPHONIA (Voice became scratchy/Voice hoarseness progressing from littele to very hoarsing). On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection arm extremely sore), MYALGIA (Body Aches) and CHILLS (chills). On 09-Feb-2021, DYSPHONIA (Voice became scratchy/Voice hoarseness progressing from littele to very hoarsing) had resolved. At the time of the report, VACCINATION SITE PAIN (injection arm extremely sore), MYALGIA (Body Aches) and CHILLS (chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported. No treatment of these events were reported.   This case was linked to MOD-2021-239296 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Update new dose-1 event and dose-2 information. On 02-Aug-2021: Non-Significant Follow-up, Reporter's contact details updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Product administered at inappropriate site
Clinical narrative: Thinks the site of injection was too low; Injection also hurt; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Thinks the site of injection was too low) and INJECTION SITE PAIN (Injection also hurt) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Thinks the site of injection was too low) and INJECTION SITE PAIN (Injection also hurt). At the time of the report, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Thinks the site of injection was too low) and INJECTION SITE PAIN (Injection also hurt) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no relevant concomitant medications was reported. No treatment information was provided Med Info Agent: Maximiliano Cengarle Crosslink with Case MOD21-042058   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Non-Significant Follow up: AE contact information updated.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Chills, Headache, Nausea
Clinical narrative: had 140/87 mmhg of blood pressure; chills; nausea; headache; sore right arm; A spontaneous report was received from a consumer who is 53 year male who experienced a headache, chills, nausea, vaccination site pain, and increased blood pressure.  The patient's medical history was not provided. Concomitant product included losartan 100 mg daily, atorvastatin 40 mg daily, and baby aspirin.  On 25-FEB-2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Batch number: 024M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.    On 25-FEB-2021 the patient reports experiencing soreness in the his right arm until 27-FEB-2021. On 28-FEB-2021 he developed a headache, then on 01-MAR-2021 he began having chills and nausea, and also mentioned having a blood pressure of140/87 mmhg (reports his normal levels are around 126-129/79 mmhg)  Action taken with mRNA-1273 in response to the event(s) was not provided/unknown.  The outcome of the events, headache, chills, nausea, pain in right arm, and increased blood pressure, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: had 140/87 mmhg of blood pressure; chills; nausea; headache; sore right arm; A spontaneous report was received from a consumer who is 53 year male who experienced a headache, chills, nausea, vaccination site pain, and increased blood pressure.  The patient's medical history was not provided. Concomitant product included losartan 100 mg daily, atorvastatin 40 mg daily, and baby aspirin.  On 25-FEB-2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Batch number: 024M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.    On 25-FEB-2021 the patient reports experiencing soreness in the his right arm until 27-FEB-2021. On 28-FEB-2021 he developed a headache, then on 01-MAR-2021 he began having chills and nausea, and also mentioned having a blood pressure of140/87 mmhg (reports his normal levels are around 126-129/79 mmhg)  Action taken with mRNA-1273 in response to the event(s) was not provided/unknown.  The outcome of the events, headache, chills, nausea, pain in right arm, and increased blood pressure, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: vaccination site sore; Minor rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site sore) and VACCINATION SITE RASH (Minor rash) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site sore) and VACCINATION SITE RASH (Minor rash). At the time of the report, VACCINATION SITE PAIN (vaccination site sore) and VACCINATION SITE RASH (Minor rash) outcome was unknown.            Concomitant medications were not provided. Treatment details were not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: itching at the injection site; Redness at the injection site; looks like a rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE RASH (looks like a rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE RASH (looks like a rash). At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE RASH (looks like a rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment a beta blocker, a blood thinner and thyroid medicine.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: experiencing bad ringing in both ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (experiencing bad ringing in both ears) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030m20a and 042l20a) for COVID-19 vaccination.     Concomitant products included LOSARTAN and METOPROLOL for an unknown indication.   On 21-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced TINNITUS (experiencing bad ringing in both ears). At the time of the report, TINNITUS (experiencing bad ringing in both ears) had not resolved.            Treatment medication included lipo flavonoid Action taken with mRNA-1273 in response to the event was not applicable
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Injection site mass, Injection site warmth, Pain in extremity
Clinical narrative: 3" red hot circle at the injection site; left elbow started bothering her; left arm started itching/more left arm itching; hard lump at the injection site; warm left arm; tender left arm; mild soreness in her left arm; little fogginess; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (mild soreness in her left arm), FEELING ABNORMAL (little fogginess), INJECTION SITE MASS (hard lump at the injection site), INJECTION SITE WARMTH (warm left arm) and TENDERNESS (tender left arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroidectomy. Concurrent medical conditions included Drug allergy (Levaquin and cipro.). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and LIOTHYRONINE for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (mild soreness in her left arm), FEELING ABNORMAL (little fogginess) and HEADACHE (headaches). On 26-Feb-2021, the patient experienced INJECTION SITE MASS (hard lump at the injection site), INJECTION SITE WARMTH (warm left arm) and TENDERNESS (tender left arm). On 28-Feb-2021, the patient experienced VACCINATION SITE REACTION (left elbow started bothering her) and VACCINATION SITE PRURITUS (left arm started itching/more left arm itching). On 01-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (3" red hot circle at the injection site). On 21-Feb-2021, PAIN IN EXTREMITY (mild soreness in her left arm), FEELING ABNORMAL (little fogginess) and HEADACHE (headaches) had resolved. At the time of the report, INJECTION SITE MASS (hard lump at the injection site), INJECTION SITE WARMTH (warm left arm), TENDERNESS (tender left arm), VACCINATION SITE REACTION (left elbow started bothering her), VACCINATION SITE PRURITUS (left arm started itching/more left arm itching) and VACCINATION SITE ERYTHEMA (3" red hot circle at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment provided
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: 3" red hot circle at the injection site; left elbow started bothering her; left arm started itching/more left arm itching; hard lump at the injection site; warm left arm; tender left arm; mild soreness in her left arm; little fogginess; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (mild soreness in her left arm), FEELING ABNORMAL (little fogginess), INJECTION SITE MASS (hard lump at the injection site), INJECTION SITE WARMTH (warm left arm) and TENDERNESS (tender left arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroidectomy. Concurrent medical conditions included Drug allergy (Levaquin and cipro.). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and LIOTHYRONINE for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (mild soreness in her left arm), FEELING ABNORMAL (little fogginess) and HEADACHE (headaches). On 26-Feb-2021, the patient experienced INJECTION SITE MASS (hard lump at the injection site), INJECTION SITE WARMTH (warm left arm) and TENDERNESS (tender left arm). On 28-Feb-2021, the patient experienced VACCINATION SITE REACTION (left elbow started bothering her) and VACCINATION SITE PRURITUS (left arm started itching/more left arm itching). On 01-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (3" red hot circle at the injection site). On 21-Feb-2021, PAIN IN EXTREMITY (mild soreness in her left arm), FEELING ABNORMAL (little fogginess) and HEADACHE (headaches) had resolved. At the time of the report, INJECTION SITE MASS (hard lump at the injection site), INJECTION SITE WARMTH (warm left arm), TENDERNESS (tender left arm), VACCINATION SITE REACTION (left elbow started bothering her), VACCINATION SITE PRURITUS (left arm started itching/more left arm itching) and VACCINATION SITE ERYTHEMA (3" red hot circle at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment provided